Vemurafenib and Triptorelin: Interaction Details
- Vemurafenib
- Zelboraf
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Vemurafenib and Triptorelin interaction:
Triptorelin
We don't have a drug information page for Triptorelin yet. Have a question about Triptorelin? Ask a pharmacist, free →
What Happens When You Take Vemurafenib With Triptorelin
What can happen when they are taken together (rated Major)
Increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Through their androgen-depriving effect, gonadotropin-releasing hormone (GnRH) and lengthen the .234 Vemurafenib likewise produces dose-dependent QT-interval prolongation, which may progress to life-threatening .
The combination of vemurafenib with a GnRH agonist or antagonist should be avoided. Where co-administration cannot be avoided, and electrolytes should be evaluated at baseline, after treatment is started, and after every vemurafenib dose modification made for QT-interval prolongation.
Monitoring should also occur after 15 days of treatment, monthly for the first 3 months, and every 3 months after that, or as clinically indicated. Vemurafenib should be discontinued if values remain above 500 msec and more than 60 msec over baseline.1
The Vemurafenib and Triptorelin Interaction, Explained
Both vemurafenib (a melanoma medicine) and triptorelin (a hormone-lowering treatment, often used for prostate cancer) can affect the heart's electrical rhythm, a change called . Taken together, these effects may add up. In rare cases, a very long QT can lead to a dangerous irregular heartbeat. This concern is based on how the drugs work, not on proven cases.
Because it's listed as a major interaction, your care team may usually avoid this pairing. If you need both, they can check your heart tracing () and blood salts regularly. Please keep taking your medicines as prescribed and talk with your pharmacist or doctor about any fainting, dizziness, or racing heartbeat.
Interaction: (). Vemurafenib causes dose-dependent QT prolongation (risk of ); GnRH such as triptorelin prolong QT via androgen deprivation.
- Evidence: theoretical; onset unspecified; severity major.
- Management: avoid if possible. If essential, obtain and electrolytes at baseline, after initiation, after any vemurafenib dose adjustment for QT prolongation, at day 15, monthly for the first 3 months, then every 3 months or as clinically indicated.
- Discontinue vemurafenib if persistently exceeds 500 msec and rises more than 60 msec from baseline.
See the 4 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Vemurafenib and Triptorelin Interact
The likely mechanism
effects on the
How to Manage the Vemurafenib and Triptorelin Interaction
Your care team will usually try to avoid using these two together. If both are truly needed, they can manage the risk with careful heart and lab monitoring.
- Expect an and blood salt (electrolyte) checks before starting, after starting, and after any vemurafenib dose change.
- Checks are also typically done around day 15, monthly for the first 3 months, then about every 3 months or as your team sees fit.
- If your heart tracing shows a persistently long QT, your doctor may decide to stop vemurafenib.
Keep taking both as prescribed and don't change anything on your own. Tell your pharmacist or prescriber about fainting, dizziness, palpitations, or other medicines you take.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Vemurafenib or Triptorelin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Vemurafenib and Triptorelin: Common Questions
How serious is the Vemurafenib and Triptorelin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Vemurafenib and Triptorelin interaction managed?
Your care team will usually try to avoid using these two together. If both are truly needed, they can manage the risk with careful heart and lab monitoring. Expect an and blood salt (electrolyte) checks before starting, after starting, and after any vemurafenib dose change. Checks are also typically done around day 15, monthly for the first 3 months, then about every 3 months or as your team s… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Vemurafenib and Triptorelin Interaction
Ask in your own words about taking Vemurafenib and Triptorelin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (4)
- Product Information: ZELBORAF(R) oral tablets, vemurafenib oral tablets. Genentech USA, Inc. (per FDA), South San Francisco, CA, 2014. DailyMed
- Product Information: TRELSTAR(R) intramuscular injection suspension, triptorelin pamoate intramuscular injection suspension. Actavis Pharma, Inc. (per FDA), Parsippany, NJ, 2014.
- Product Information: VANTAS(R) subcutaneous implant, histrelin acetate subcutaneous implant. Endo Pharmaceuticals Solutions Inc. (per DailyMed), Malvern, PA, 2014. DailyMed
- Product Information: LUPRON DEPOT intramuscular injection depot suspension, leuprolide acetate intramuscular injection depot suspension. AbbVie Inc. (per FDA), North Chicago, IL, 2014.
Other Serious Interactions of Vemurafenib and Triptorelin
Also serious with Vemurafenib
- ColchicineContraindicated
- Ketoconazole TopicalContraindicated
- DronedaroneContraindicated
- KetoconazoleContraindicated
Also serious with Triptorelin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Vemurafenib
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 162 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.